You are viewing the site in preview mode

Skip to main content

Table 1 Correlation between CASC11 and clinicopathological characteristics (n = 50)

From: LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway

Clinicopathologic feature N (%) CASC11 (mean ± SEM) p-value
Age 0.836
 ≤ 60 19 (38%) 1.23 ± 0.17  
 > 60 31 (62%) 1.17 ± 0.20  
Tumor size (cm) 0.047*
 < 4 38 (76%) 1.05 ± 0.12  
 ≥ 4 12 (24%) 1.42 ± 0.15  
Menopause  
 Yes 26 (52%) 1.29 ± 0.17 0.925
 No 24 (48%) 1.30 ± 0.14  
Lymph node metastasis  
 Negative 23 (46%) 1.25 ± 0.20 0.918
 Positive 27 (54%) 1.27 ± 0.18  
Lymphativ vascular space invasion  
 Negative 29 (58%) 1.23 ± 0.12 0.816
 Positive 21 (42%) 1.36 ± 0.10  
FIGO stage 0.043*
 I 38 (78%) 1.03 ± 0.15  
 II 12 (24%) 1.39 ± 0.16  
  1. *p < 0.5